Home › Funds › D. E. Shaw & Co › MDGL
D. E. Shaw & Co position in MDGL
MADRIGAL PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)162.27K sh
Reported value held$87.13M
Portfolio Weight0.05%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 48.22K | $3.85M | New |
| Q4 2021 | 32.49K | $2.75M | Reduce |
| Q1 2022 | 22.77K | $2.23M | Reduce |
| Q2 2022 | 22.18K | $1.59M | Reduce |
| Q3 2022 | 22.98K | $1.49M | Add |
| Q4 2022 | 153.44K | $44.54M | Add |
| Q1 2023 | 28.74K | $6.96M | Reduce |
| Q2 2023 | 9.40K | $2.17M | Reduce |
| Q3 2023 | 30.41K | $4.44M | Add |
| Q4 2023 | 50.12K | $11.60M | Add |
| Q1 2024 | 67.96K | $18.15M | Add |
| Q2 2024 | 46.75K | $13.10M | Reduce |
| Q3 2024 | 53.80K | $11.42M | Add |
| Q4 2024 | 101.94K | $31.46M | Add |
| Q1 2025 | 129.91K | $43.03M | Add |
| Q2 2025 | 143.68K | $43.48M | Add |
| Q3 2025 | 174.78K | $80.17M | Add |
| Q4 2025 | 193.65K | $112.77M | Add |
| Q1 2026 | 127.34K | $66.66M | Reduce |
| Q2 2026 | 162.27K | $87.13M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MDGL
- Vanguard Group 1.81M sh · $1.05B · Q4 2025
- Janus Henderson Group 2.02M sh · $1.05B · Q1 2026
- Paulson & Co 1.34M sh · $719.52M · Q2 2026
- BlackRock Inc 1.20M sh · $644.75M · Q2 2026
- Wellington Management Group 825.71K sh · $443.37M · Q2 2026
- Citadel Advisors 688.13K sh · $369.49M · Q2 2026
- UBS Group AG 401.71K sh · $215.70M · Q2 2026
- Geode Capital Management 374.88K sh · $201.34M · Q2 2026
- Fidelity Management & Research (FMR) 356.20K sh · $191.26M · Q2 2026
- Invesco Ltd 301.44K sh · $161.86M · Q2 2026
- Goldman Sachs Group 246.28K sh · $132.24M · Q2 2026
- Norges Bank Investment Management 213.89K sh · $114.85M · Q2 2026